Old Web
English
Sign In
Acemap
>
Paper
>
Abstract PR08: Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations
Abstract PR08: Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations
2019
Alan L. Ho
Irene Brana
Robert I. Haddad
Jessica Bauman
Keith C. Bible
Laurence Faugeras
Sjoukje F. Oosting
Deborah J. Wong
Myung Ju Ahn
Valentina Boni
Caroline Even
Jérôme Fayette
María José Flor
Kevin J. Harrington
Sung Bae Kim
Lisa Licitra
Ioanna Nixon
Nabil F. Saba
Cyrus Sayehli
Pol Specenier
Francis P. Worden
Binaifer Balsara
Jeanne Britt
Vishnu Mishra
Catherine Scholz
Antonio Gualberto
Keywords:
HRAS
Cancer research
Statistics
Cell
Medicine
Tipifarnib
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]